Source:http://linkedlifedata.com/resource/pubmed/id/16531820
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2006-3-13
|
pubmed:abstractText |
The goal of vaccination against tumors is the induction of effector T cells mediating tumor destruction and memory T cells providing long-term immunity. Several previous studies in patients vaccinated with major histocompatibility complex (MHC) class I peptides failed to show induction of central memory T cells, which are considered important to provide long-term memory. This study examined the subset composition and function of specific T cells generated by immunization with MHC class I binding tyrosinase peptides in combination with the adjuvants granulocyte-macrophage colony-stimulating factor and keyhole limpet hemocyanin in peripheral blood (PB) and bone marrow (BM) of melanoma patients. Most of the tyrosinase-specific T cells in PB had a CD45RA(+)CCR7(-) effector phenotype. In contrast to this, a large subset of tyrosinase-specific T cells in BM were memory T cells, including CD45RA(+)CCR7(-) central and CD45RA(-)CCR7(-) effector memory T cells. BM tyrosinase-specific T cells were functional, because they produced interferon-gamma and had a high proliferative potential. This study suggests that peptide vaccination can generate a fully functional memory T-cell response characterized by central and effector memory phenotypes, proliferative potential, and BM tropism.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1524-9557
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
201-7
|
pubmed:dateRevised |
2008-3-18
|
pubmed:meshHeading |
pubmed-meshheading:16531820-Bone Marrow,
pubmed-meshheading:16531820-Cancer Vaccines,
pubmed-meshheading:16531820-Clinical Trials, Phase II as Topic,
pubmed-meshheading:16531820-Histocompatibility Antigens Class I,
pubmed-meshheading:16531820-Humans,
pubmed-meshheading:16531820-Immunologic Memory,
pubmed-meshheading:16531820-Melanoma,
pubmed-meshheading:16531820-Monophenol Monooxygenase,
pubmed-meshheading:16531820-T-Lymphocyte Subsets
|
pubmed:articleTitle |
Specific central memory T cells in the bone marrow of patients immunized against tyrosinase peptides.
|
pubmed:affiliation |
Department of Hematology, Oncology, and Transfusion Medicine, Charité, Campus Benjamin Franklin, Berlin, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|